|
End-of-day quote
Korea S.E.
18/11/2026
|
5-day change | 1st Jan Change | ||
| 22,550.00 KRW | +1.58% |
|
+1.81% | -14.74% |
| 02:55am | Lotte Biologics Completes Songdo Biopharmaceutical Plant; Commercial Production to Start in 2027 | MT |
| 10-30 | Lotte Discloses KRW10.2 Billion Brand-Use Transaction with Affiliate Lotte Rental | MT |
Company Valuation: LOTTE Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 2,150,618 | 2,211,597 | 1,942,156 | 1,562,983 | 2,031,297 | 1,731,576 | - | - |
| Change | - | 2.84% | -12.18% | -19.52% | 29.96% | -14.76% | - | - |
| Enterprise Value (EV) 1 | 6,979 | 8,554 | 8,674 | 8,632 | 9,353 | 10,538 | 10,320 | 1,732 |
| Change | - | 22.57% | 1.4% | -0.48% | 8.35% | 12.66% | -2.07% | -83.22% |
| P/E | 6.93x | 12.9x | -126x | -1.52x | -2.93x | 15.8x | 12.8x | - |
| PBR | 0.3x | 0.31x | 0.28x | 0.37x | 0.46x | 0.29x | 0.39x | 0.29x |
| PEG | - | -0.3x | 1x | -0x | 0.1x | -0x | 0.5x | - |
| Capitalization / Revenue | 0.22x | 0.16x | 0.13x | 0.1x | 0.13x | 0.11x | 0.1x | 0.1x |
| EV / Revenue | 0.7x | 0.61x | 0.57x | 0.55x | 0.6x | 0.67x | 0.63x | 0.1x |
| EV / EBITDA | 8.93x | 46.2x | 6.54x | 6.63x | 7.76x | 8.11x | 7.18x | 1.33x |
| EV / EBIT | 32.8x | 17.4x | 17.7x | 25.9x | 39.1x | 31.9x | 22.1x | 3.47x |
| EV / FCF | 50.5x | 57.9x | 18.7x | -33.8x | -60.7x | 13.8x | 12.6x | 1.38x |
| FCF Yield | 1.98% | 1.73% | 5.34% | -2.96% | -1.65% | 7.23% | 7.93% | 72.2% |
| Dividend per Share 3 | 1,500 | - | 1,500 | 1,200 | 1,250 | 1,250 | 1,350 | 1,250 |
| Rate of return | 5.02% | - | 5.55% | 5.5% | 4.73% | 5.54% | 5.99% | 5.54% |
| EPS 3 | 4,315 | 2,387 | -215 | -14,389 | -9,028 | 1,427 | 1,764 | - |
| Distribution rate | 34.8% | - | -698% | -8.34% | -13.8% | 87.6% | 76.5% | - |
| Net sales 1 | 9,926 | 14,001 | 15,155 | 15,730 | 15,540 | 15,831 | 16,492 | 17,041 |
| EBITDA 1 | 781.8 | 185.3 | 1,326 | 1,302 | 1,206 | 1,299 | 1,438 | 1,299 |
| EBIT 1 | 212.6 | 491.8 | 489.2 | 333.9 | 239.4 | 330.6 | 465.9 | 499 |
| Net income 1 | 156.7 | 329.6 | -15.36 | -938.2 | -615.2 | 102 | 126 | - |
| Net Debt 1 | 4,828 | 6,343 | 6,732 | 7,069 | 7,322 | 8,806 | 8,588 | - |
| Reference price 3 | 29,900.00 | 30,800.00 | 27,050.00 | 21,800.00 | 26,450.00 | 22,550.00 | 22,550.00 | 22,550.00 |
| Nbr of stocks (in thousands) | 71,513 | 71,532 | 71,532 | 71,532 | 76,777 | 76,777 | - | - |
| Announcement Date | 10/02/22 | 16/02/23 | 14/02/24 | 11/02/25 | 09/02/26 | - | - | - |
1KRW in Million2KRW in Billions3KRW
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 15.56x | 0.66x | 8.09x | 5.63% | 1.28B | ||
| 20.15x | 3.42x | 12.92x | -.--% | 2,789B | ||
| 29.29x | 2.07x | 15.13x | 2.96% | 60.32B | ||
| 10.46x | 0.09x | 3.77x | 3.93% | 34.18B | ||
| -17.89x | 0.55x | 36.08x | -.--% | 25.09B | ||
| 8.61x | 0.28x | 7.99x | - | 22.77B | ||
| 78.84x | 6.9x | 36.17x | 0.19% | 18.15B | ||
| 17.4x | 1.44x | 9.76x | 2.67% | 17.22B | ||
| 32.06x | 5.08x | 16.37x | -.--% | 16.87B | ||
| 38.38x | 2.78x | 19.21x | 0.67% | 16.6B | ||
| Average | 23.29x | 2.33x | 16.55x | 1.78% | 300B | |
| Weighted average by Cap. | 20.32x | 3.32x | 13.19x | 0.13% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- A004990 Stock
- Valuation LOTTE Corporation
Select your edition
All financial news and data tailored to specific country editions
















